are glp 1 drugs lifelong Research Suggests GLP-1 Could Be for the Long Haul Chart: 1 in 8 Americans

One AssuredPartners case study found GLP1 users saved about $560 per person per year in medical costs but against an average annual drug cost of $6,540, the nearterm ROI is negative for most employers

"If you ignore something like that, that's going to send a horrendous message through the rest of the ranks

In an in vivo study, administration of MOTS-c intraperitoneally to de-ovalized osteoporotic mice once daily for 12 weeks at a dose of 5 mg/kg, lead to an increased positive trend in several bone formation parameters, such as bone mineral density, bone volume/tissue volume, bone trabecule number, and bone trabecule thickness, indicating that the MOTS-c intervention effectively reduced bone loss

10.3390/biomedicines11061567 64 KimY